Yaping Xu

794 total citations
44 papers, 523 citations indexed

About

Yaping Xu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yaping Xu has authored 44 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 14 papers in Oncology. Recurrent topics in Yaping Xu's work include Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (13 papers) and Esophageal Cancer Research and Treatment (8 papers). Yaping Xu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (13 papers) and Esophageal Cancer Research and Treatment (8 papers). Yaping Xu collaborates with scholars based in China, United States and Malaysia. Yaping Xu's co-authors include Fei Zhou, Qinghua Xu, Tao Jiang, Xuefei Li, Hui Liu, Caicun Zhou, Weimin Mao, Xiaojiang Sun, Hui Liu and Fangjuan Li and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Clinical Gastroenterology and Hepatology.

In The Last Decade

Yaping Xu

39 papers receiving 520 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaping Xu China 13 358 236 120 76 59 44 523
Won Kyung Cho South Korea 12 165 0.5× 207 0.9× 135 1.1× 56 0.7× 72 1.2× 56 462
Tone Fokstuen Sweden 10 151 0.4× 418 1.8× 224 1.9× 33 0.4× 43 0.7× 18 511
Steffi Rombouts Netherlands 8 125 0.3× 304 1.3× 101 0.8× 54 0.7× 28 0.5× 15 434
Jiaying Deng China 13 271 0.8× 158 0.7× 260 2.2× 46 0.6× 72 1.2× 40 447
Whitney S. Brandt United States 11 208 0.6× 75 0.3× 42 0.3× 51 0.7× 77 1.3× 29 320
Nishan H. Fernando United States 9 142 0.4× 259 1.1× 127 1.1× 31 0.4× 84 1.4× 13 390
Philip Philip United States 9 173 0.5× 361 1.5× 143 1.2× 38 0.5× 61 1.0× 23 480
Kunli Zhu China 13 97 0.3× 233 1.0× 113 0.9× 35 0.5× 55 0.9× 28 342
Samir Darwish Italy 12 311 0.9× 250 1.1× 38 0.3× 30 0.4× 116 2.0× 17 441
Yimei Jiang China 10 123 0.3× 188 0.8× 132 1.1× 15 0.2× 145 2.5× 25 386

Countries citing papers authored by Yaping Xu

Since Specialization
Citations

This map shows the geographic impact of Yaping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaping Xu more than expected).

Fields of papers citing papers by Yaping Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaping Xu. The network helps show where Yaping Xu may publish in the future.

Co-authorship network of co-authors of Yaping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaping Xu. A scholar is included among the top collaborators of Yaping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaping Xu. Yaping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yaping, Chundong Yu, Hongbin Zhang, et al.. (2024). Downregulation of Brf1 Induces Liver Failure and Inhibits Hepatocellular Carcinoma Progression by Promoting Apoptosis. Journal of Cancer. 15(17). 5577–5593. 1 indexed citations
2.
Xu, Yaping, Xiangli Zhang, Ziyu Liu, et al.. (2024). Intrapericardial Administration of Human Pericardial Fluid Cells Improves Cardiac Functions in Rats with Heart Failure. Stem Cells and Development. 33(21-22). 616–629.
3.
Xu, Yaping, et al.. (2024). Intrapericardial Administration to Achieve Localized and Targeted Treatment for Cardiac Disease. Journal of Cardiovascular Translational Research. 18(1). 28–39.
4.
Cheng, Qian, Ying Zhang, Xiaoshuai Yuan, et al.. (2024). Clinical predictors of severe radiation pneumonitis in patients undergoing thoracic radiotherapy for lung cancer. Translational Lung Cancer Research. 13(5). 1069–1083. 6 indexed citations
5.
Jiang, Yawen, et al.. (2024). How to tackle non-specific low back pain among adult patients? A systematic review with a meta-analysis to compare four interventions. Journal of Orthopaedic Surgery and Research. 19(1). 1–1. 4 indexed citations
6.
Xu, Yaping, et al.. (2023). Spontaneous visual database for detecting learning-centered emotions during online learning. Image and Vision Computing. 136. 104739–104739. 8 indexed citations
7.
8.
Yang, Shuangyan, Lucyna Kępka, Gustavo Arruda Viani, et al.. (2023). Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study. Translational Lung Cancer Research. 12(6). 1293–1302. 2 indexed citations
9.
Li, Huihui, et al.. (2023). Applications of lung cancer organoids in precision medicine: from bench to bedside. Cell Communication and Signaling. 21(1). 350–350. 16 indexed citations
10.
Zhang, Ran, Jingjing Kang, Shengxiang Ren, Ligang Xing, & Yaping Xu. (2022). Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis. Annals of Translational Medicine. 10(2). 104–104. 13 indexed citations
11.
Luan, Ting, et al.. (2021). A Radiomics Nomogram for Preoperative Prediction of Clinical Occult Lymph Node Metastasis in cT1-2N0M0 Solid Lung Adenocarcinoma. Cancer Management and Research. Volume 13. 8157–8167. 10 indexed citations
12.
Xu, Yaping, Yingqun Zhou, Yujie Zhao, et al.. (2021). Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma. Digestive Diseases and Sciences. 67(2). 559–568. 6 indexed citations
13.
Li, Qian, Ying Tong, Guanzhong Gong, Yong Yin, & Yaping Xu. (2021). The margin of internal risk volume on atrial septal and ventricular septal based on electrocardiograph gating 4DCT. Annals of Translational Medicine. 9(10). 842–842. 2 indexed citations
14.
Li, Fangjuan, Hui Liu, Hongyu Wu, Shi‐Xiong Liang, & Yaping Xu. (2021). Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy. Radiation Oncology. 16(1). 70–70. 27 indexed citations
15.
Li, Yefei, et al.. (2020). Association between IDO activity and prognosis in patients with non-small cell lung cancer after radiotherapy. Annals of Translational Medicine. 8(18). 1169–1169. 12 indexed citations
16.
Wu, Ran, et al.. (2020). Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease. Translational Lung Cancer Research. 9(6). 2328–2336. 12 indexed citations
17.
18.
Sun, Xiaojiang, Yefei Li, Qian Li, et al.. (2020). Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer. Translational Lung Cancer Research. 9(4). 1472–1482. 5 indexed citations
19.
Sun, Xiaojiang, et al.. (2014). FDG-PET/CT imaging for tumor staging and definition of tumor volumes in radiation treatment planning in non-small cell lung cancer. Oncology Letters. 7(4). 1015–1020. 16 indexed citations
20.
Xu, Yaping, et al.. (2003). Correlation of matrix metalloproteinase-2, −9, tissue inhibitor-1 of matrix metalloproteinase and CD44 variant 6 in head and neck cancer metastasis. Journal of Zhejiang University. Science A. 4(4). 491–501. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Won Kyung Cho Breakdown of academic impact, for papers by Tone Fokstuen Breakdown of academic impact, for papers by Steffi Rombouts Breakdown of academic impact, for papers by Jiaying Deng Breakdown of academic impact, for papers by Whitney S. Brandt Breakdown of academic impact, for papers by Nishan H. Fernando Breakdown of academic impact, for papers by Philip Philip Breakdown of academic impact, for papers by Kunli Zhu Breakdown of academic impact, for papers by Samir Darwish Breakdown of academic impact, for papers by Yimei Jiang
Rankless by CCL
2026